X

Blog

FDA Gives Orphan Drug Designation to CytRx Corp. (CYTR) Pancreatic Cancer Treatment

Oncology-focused biotech company CytRx Corp. today announced that its tumor-targeting pro-drug candidate INNO-206 has been approved for orphan drug designation…

QualityStocks

Network Engines, Inc. (NEI) Q2 Results Beat Guidance with Sixth Straight Quarter of Profits

NEI, a leading global provider of server-based application platforms, deployment solutions and lifecycle support services for software technology developers and…

QualityStocks

True 2 Beauty, Inc. (TRTB) Continues Marketing Move Into Television

Earlier this month, True 2 Beauty, leading distributor of all-natural pills and liquid products for male and female sexual enhancement,…

QualityStocks

Camtek Ltd. (CAMT) Q1 Earnings Rise 56%

Camtek Ltd., a provider of automated solutions dedicated for enhancing production processes and yield, today announced its financial results for…

QualityStocks

Openwave Systems Inc. (OPWV) Video Chart for Thursday, April 28, 2011

OPWV is taking on the look of a descending triangle, but it is holding a firm support level as well…

QualityStocks

Spare Backup, Inc. (SPBU) and Wirefly Launch Mobile Backup PRO

Yesterday, Spare Backup, Inc. announced it would be growing its current relationship with Internet cell phone retailer Wirefly to launch…

QualityStocks

Cinedigm Digital Cinema Corp. (CIDM) Enters into Deployment Agreement with SR Entertainment Group

Cinedigm Digital Cinema Corp., a global leader in digital cinema, announced yesterday that they have entered into a long-term VPF…

QualityStocks

Inventure Foods Inc. (SNAK) Reports Earnings Up 16%

Inventure Foods Inc., a leading specialty food maker and marketer, today reported its financial results for the first quarter ended…

QualityStocks

Sharps Compliance Corp. (SMED) Posts 24% Revenue Increase for Q3

Sharps Compliance Corp., a leading full-service provider of cost-effective management solutions for medical waste and unused dispensed medications generated outside…

QualityStocks

Unigene Laboratories, Inc. (UGNE) Achieves Enrollment Target for Oral PTH Phase 2 in Osteoporotic Postmenopausal Women, Secures $4M Milestone Payment from GlaxoSmithKline

Unigene Laboratories, developers of one of the top portfolios in existence of peptide-based therapeutics, a portfolio engineered on the Company’s…

QualityStocks